These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
207 related articles for article (PubMed ID: 26801673)
1. Biological characteristics of a novel giant cell tumor cell line derived from spine. Zhou Z; Li Y; Xu L; Wang X; Chen S; Yang C; Xiao J Tumour Biol; 2016 Jul; 37(7):9681-9. PubMed ID: 26801673 [TBL] [Abstract][Full Text] [Related]
2. ALCAM Zhou Z; Li Y; Wang X; Hu J; Kuang M; Wang Z; Li S; Xu W; Xiao J Cell Death Dis; 2018 Feb; 9(3):299. PubMed ID: 29463803 [TBL] [Abstract][Full Text] [Related]
3. The role of the tumor suppressor RUNX3 in giant cell tumor of the bone. Han YX; Liang DY Int J Oncol; 2012 Mar; 40(3):673-8. PubMed ID: 22076387 [TBL] [Abstract][Full Text] [Related]
4. Knock-down of oncohistone H3F3A-G34W counteracts the neoplastic phenotype of giant cell tumor of bone derived stromal cells. Fellenberg J; Sähr H; Mancarella D; Plass C; Lindroth AM; Westhauser F; Lehner B; Ewerbeck V Cancer Lett; 2019 Apr; 448():61-69. PubMed ID: 30742944 [TBL] [Abstract][Full Text] [Related]
5. Phenotypic and molecular studies of giant-cell tumors of bone and soft tissue. Lau YS; Sabokbar A; Gibbons CL; Giele H; Athanasou N Hum Pathol; 2005 Sep; 36(9):945-54. PubMed ID: 16153456 [TBL] [Abstract][Full Text] [Related]
6. Prognostic impact of reduced connexin43 expression and gap junction coupling of neoplastic stromal cells in giant cell tumor of bone. Balla P; Maros ME; Barna G; Antal I; Papp G; Sapi Z; Athanasou NA; Benassi MS; Picci P; Krenacs T PLoS One; 2015; 10(5):e0125316. PubMed ID: 25933380 [TBL] [Abstract][Full Text] [Related]
7. Immunohistochemical analyses of beta-catenin and cyclin D1 expression in giant cell tumor of bone (GCTB): a possible role of Wnt pathway in GCTB tumorigenesis. Matsubayashi S; Nakashima M; Kumagai K; Egashira M; Naruke Y; Kondo H; Hayashi T; Shindo H Pathol Res Pract; 2009; 205(9):626-33. PubMed ID: 19324500 [TBL] [Abstract][Full Text] [Related]
9. CD33+ CD14- phenotype is characteristic of multinuclear osteoclast-like cells in giant cell tumor of bone. Forsyth RG; De Boeck G; Baelde JJ; Taminiau AH; Uyttendaele D; Roels H; Praet MM; Hogendoorn PC J Bone Miner Res; 2009 Jan; 24(1):70-7. PubMed ID: 18767926 [TBL] [Abstract][Full Text] [Related]
10. Establishment and characterization of two novel patient-derived cell lines from giant cell tumor of bone: NCC-GCTB8-C1 and NCC-GCTB9-C1. Adachi Y; Noguchi R; Yoshimatsu Y; Sin Y; Osaki J; Ono T; Iwata S; Akiyama T; Tsuchiya R; Toda Y; Ishihara S; Ogura K; Kobayashi E; Kojima N; Yoshida A; Yokoo H; Kawai A; Kondo T Hum Cell; 2024 May; 37(3):874-885. PubMed ID: 38466561 [TBL] [Abstract][Full Text] [Related]
11. Giant cell tumor of bone: updated molecular pathogenesis and tumor biology. Noh BJ; Park YK Hum Pathol; 2018 Nov; 81():1-8. PubMed ID: 29944971 [TBL] [Abstract][Full Text] [Related]
12. Restoration of miR-127-3p and miR-376a-3p counteracts the neoplastic phenotype of giant cell tumor of bone derived stromal cells by targeting COA1, GLE1 and PDIA6. Fellenberg J; Sähr H; Kunz P; Zhao Z; Liu L; Tichy D; Herr I Cancer Lett; 2016 Feb; 371(1):134-41. PubMed ID: 26655997 [TBL] [Abstract][Full Text] [Related]
13. Stro-1(+) stromal cells have stem-like features in giant cell tumor of bone. Lan J; Liu X; Rong W; Wei F; Jiang L; Yu H; Dang G; Liu Z J Surg Oncol; 2012 Dec; 106(7):826-36. PubMed ID: 22605660 [TBL] [Abstract][Full Text] [Related]
14. Serglycin induces osteoclastogenesis and promotes tumor growth in giant cell tumor of bone. He Y; Cheng D; Lian C; Liu Y; Luo W; Wang Y; Ma C; Wu Q; Tian P; He D; Jia Z; Lv X; Zhang X; Pan Z; Lu J; Xiao Y; Zhang P; Liang Y; Yang Q; Hu G Cell Death Dis; 2021 Sep; 12(10):868. PubMed ID: 34556636 [TBL] [Abstract][Full Text] [Related]
15. Giant cell tumor of bonelike lesion in a Trp53 mutant mouse. Radaelli E; Rustighi A; Scanziani E Toxicol Pathol; 2012 Jun; 40(4):675-81. PubMed ID: 22328409 [TBL] [Abstract][Full Text] [Related]
16. Establishment and characterization of novel patient-derived cell lines from giant cell tumor of bone. Yoshimatsu Y; Noguchi R; Tsuchiya R; Ono T; Sin Y; Akane S; Sugaya J; Mori T; Fukushima S; Yoshida A; Kawai A; Kondo T Hum Cell; 2021 Nov; 34(6):1899-1910. PubMed ID: 34304386 [TBL] [Abstract][Full Text] [Related]
17. Establishment and characterization of the NCC-GCTB4-C1 cell line: a novel patient-derived cell line from giant cell tumor of bone. Ono T; Noguchi R; Yoshimatsu Y; Tsuchiya R; Sin Y; Nakagawa R; Hirabayashi K; Ozawa I; Kikuta K; Kondo T Hum Cell; 2022 Jan; 35(1):392-399. PubMed ID: 34731453 [TBL] [Abstract][Full Text] [Related]
18. Enrichment of c-Met+ tumorigenic stromal cells of giant cell tumor of bone and targeting by cabozantinib. Liu L; Aleksandrowicz E; Fan P; Schönsiegel F; Zhang Y; Sähr H; Gladkich J; Mattern J; Depeweg D; Lehner B; Fellenberg J; Herr I Cell Death Dis; 2014 Oct; 5(10):e1471. PubMed ID: 25321478 [TBL] [Abstract][Full Text] [Related]
19. Genome-Wide Transcriptome Profiling of the Neoplastic Giant Cell Tumor of Bone Stromal Cells by RNA Sequencing. Lau CP; Kwok JS; Tsui JC; Huang L; Yang KY; Tsui SK; Kumta SM J Cell Biochem; 2017 Jun; 118(6):1349-1360. PubMed ID: 27862217 [TBL] [Abstract][Full Text] [Related]
20. IL-17A stimulates the progression of giant cell tumors of bone. Xu M; Song ZG; Xu CX; Rong GH; Fan KX; Chen JY; Zhang W; Jia JP; Han G; Wang W; Chai W; Liang WT; Bi WZ; Wang Y Clin Cancer Res; 2013 Sep; 19(17):4697-705. PubMed ID: 23857601 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]